Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.97 -0.05 (-4.90%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Other Operating Expenses (2022 - 2023)

Updated

Cadrenal Therapeutics (CVKD) posted Other Operating Expenses of $60,763 for Q3 2023, down 86.1% from $435,642 a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Other Operating Expenses (2022 - 2023) Analysis & Trends

For FY2022, Cadrenal Therapeutics' Other Operating Expenses came in at $4.01 million.

  • The Q3 2023 figure stands as the lowest quarterly Other Operating Expenses since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Cadrenal Therapeutics 2.85 Mn -9.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 60,763.00
Mar 31, 2023 973,335.00
Dec 31, 2022 3.58 Mn
Sep 30, 2022 435,642.00
Mar 31, 2022 6,127.00
API Access

Cadrenal Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CVKD&period=max&api_key=YOUR_API_KEY